CADL (Candel) Kacepetan wutah bathi saben saham ing taun lumaku
Candel Therapeutics (CADL) is integrating ESG principles into the development of anticancer immunotherapies by reducing laboratory waste. On GURU.Markets, the annual earnings per share trend shows that the current metric is -80.00. The robotization of drug synthesis is accelerating development, although physicians remain indispensable. Meanwhile, the company's eco-policy remains formal, limited to digital documentation and the monitoring of chemical disposal.
Rincian metrik keuangan lan pasar candeltx.com (CADL)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Rasio Utang marang Ekuitas Candel Therapeutics|CADL - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Candel Therapeutics, Inc.|CADL - Gunggung utang perusahaan|Utang-utang marang nilai buku Candel Therapeutics, Inc.|CADL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Candel Therapeutics|Rasio jangkoan perantara candeltx.com
- data bathi resik lan rasio valuasi:
CADL - Penghasilan resik|Bathi resik mangsa ngarep Candel Therapeutics|CADL - Pangali P/E|Pangali mangsa ngarep rega marang bathi Candel Therapeutics, Inc.|CADL - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Candel Therapeutics, Inc.|CADL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Candel Therapeutics|CADL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan candeltx.com|CADL - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Candel Therapeutics
- informasi babagan volume dodolan lan pendapatan:
Pambiji fundamental:CADL Candel
The eps_yy_co metric measures the annual percentage change in earnings per share, reflecting the efficiency of profit generation or the rate of loss reduction relative to the previous year. By analyzing the relative EPS YoY dynamics, an investor can see the impact of cost management for clinical trials and grants at Candel Therapeutics (CADL), which is critical for assessing the company's financial stability prior to the commercialization stage.
Pesaing utama
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki cgoncology.com CGON|Wutah bathi ing taun lumaku URGN (UroGen Pharma)|Wutah bathi ing taun lumaku Bicara Therapeutics Inc BCAX|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS (Erasca Oncology) - Wutah bathi saben saham ing taun iki|DCTH: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki YMAB|AURA (Aura Biosciences) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Accuray Inc ARAY|Wutah bathi saben saham ing taun lumaku SELLAS Life Sciences (SLS)|Wutah bathi saben saham ing taun lumaku ACTU (Actuate Therapeutics Inc)|Citius Oncology, Inc. - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku HURA|TARA: Wutah bathi resik saben saham ing taun iki|Fate Therapeutics Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|WHWK: Wutah bathi ing taun lumaku|TScan Therapeutics, Inc. - Tambahing bathi saben saham ing taun lumaku|CSBR (Champions Oncology Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku XBiotech USA XBIT|Wutah bathi saben saham ing taun lumaku CEL-SCI Corporation (CVM)|OSTX (OS Therapies Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku RADX (Radiopharm Theranostics)|Wutah bathi ing taun lumaku Artiva Biotherapeutics Inc. ARTV|ANL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku VERU|TPST: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Xilio Therapeutics (XLO)|Wutah bathi resik saben saham ing taun iki RENB|Wutah bathi ing taun lumaku Mural Bio|Wutah bathi resik saben saham ing taun iki KAPA (Kairos Pharma Ltd)|Wutah bathi resik saben siji saham kanggo taun lumaku OKUR|Wutah bathi ing taun lumaku GDTC (CytoMed Therapeutics Limited)|Prakiraan wutah bathi resik saben saham ing taun iki Curis Inc. (CRIS)|Apollomics Corp - Wutah bathi ing taun lumaku|Tharimmune Corporation (THAR) - Wutah bathi resik saben saham ing taun iki|advanbiomed.com (ADVB) - Wutah bathi saben saham ing taun lumaku|GNPX - Prakiraan wutah bathi resik saben saham ing taun iki|CLDI (Calidi Biotherapeutics Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki sunshinebiopharma.com (SBFM)|Wutah bathi ing taun lumaku XBIO|Wutah bathi ing taun lumaku Salarius Pharma (SLRX)|Wutah bathi ing taun lumaku PPBT (Purple Biotech)|AONC: Wutah bathi saben saham ing taun iki|BGNE - Wutah bathi saben saham ing taun lumaku|CKPT: Wutah bathi saben saham ing taun lumaku|ELEV: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki iCAD|IKNA (Ikena Oncology Inc.) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku notablelabs.com|Wutah bathi saben saham ing taun lumaku Viracta Therapeutics (VIRX)|MorphoSys Inc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku NAYA (NAYA Bio)|AAPGV - Wutah bathi resik saben saham ing taun iki
